Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022.
| Autor: | Carr, Wendy1, Kurbatova, Ekaterina1, Starks, Angela1, Goswami, Neela1, Allen, Leeanna1, Winston, Carla1 |
|---|---|
| Zdroj: | MMWR: Morbidity & Mortality Weekly Report. 2/25/2022, Vol. 71 Issue 8, p285-289. 5p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|